BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Pharmaceuticals
| Rights History | ||||||
| Announcement Date | Rights Ratio | Face Value | Premium | Record Date | Ex-Rights Date | |
| No rights information available for Novartis India | ||||||
 | ||||||
| ||||||
| Source : Religare Technova | ||||||
| ||||||
'India will be a great power by 2025'
Arvind Virmani
Rajdeep Sardesai looks back at a decade of television news
Rajdeep Sardesai
Daily Markets Newsletter
Daily Portfolio Update
MF Newsletters
PF Newsletters
Editor-in-Chief , Forbes
(24 Nov- 18:30hrs)
Nov 25 | 04:00 PM
Ramesh Damani
Nov 30 | 12:00 PM
Hemant Luthra
Dec 01 | 11:00 AM
Harsh Mariwala
| NEWS |
| Business News |
| Management Interviews (transcripts) |
| Economic News |
| BSE&NSE Notices |
| CNBC-TV18 Transcripts |
| STOCKS & IPO |
| Stock Advice |
| Technical Calls |
| Brokerage Reports |
| IPO News |
| IPO Expert Advice |
| EARNINGS |
| Pre Result Estimates |
| Results |
| Boardroom (transcripts) |
| Result Analysis (transcripts) |
| Brokerage Reports |
| MF & PF |
| Wealth Tips |
| Expert Advice |
| MF News |
| MF Analysis |
| MF Interviews |
|
Connect.in.com
Online
